Page last updated: 2024-10-20

pyrazinamide and Nasal Obstruction

pyrazinamide has been researched along with Nasal Obstruction in 3 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Nasal Obstruction: Any hindrance to the passage of air into and out of the nose. The obstruction may be unilateral or bilateral, and may involve any part of the NASAL CAVITY.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bouchentouf, R2
Bouaity, B2
Touati, M2
Benjelloun, A1
Ali Aitbenasser, M1
Aljalil, A1
Chihani, M1
Ammar, H1
Lerra, S1
Nazir, T1
Mir Qadri, S1
Kirmani, M1

Reviews

1 review available for pyrazinamide and Nasal Obstruction

ArticleYear
[Pseudotumor form of primary nasopharyngeal tuberculosis: apropos of 2 new cases and review of the literature].
    The Pan African medical journal, 2013, Volume: 14

    Topics: Antitubercular Agents; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Humans; Isoniazid

2013

Other Studies

2 other studies available for pyrazinamide and Nasal Obstruction

ArticleYear
[Primary sinonasal tuberculosis: apropos of a case].
    The Pan African medical journal, 2013, Volume: 14

    Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Maxil

2013
Primary nasal tuberculosis-a rare clinical entity.
    Ear, nose, & throat journal, 2011, Volume: 90, Issue:7

    Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Epistaxis; Female; Humans; Isoniazid; Nasal

2011